Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
No intraday reading yet this session.
Arrowhead Pharmaceuticals, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“On September 28, 2016, Amgen and the Company entered into two collaboration and license agreements and a common stock purchase agreement.”
FILING10-K0000879407-25-000029cik 0000879407
“On August 29, 2025, Novartis and the Company entered into a global licensing and collaboration agreement.”
FILING10-K0000879407-25-000029cik 0000879407
“On November 25, 2024, Sarepta and Company entered into a global licensing and collaboration agreement.”
FILING10-K0000879407-25-000029cik 0000879407
“On November 22, 2021, GSK and the Company entered into an Exclusive License Agreement (the "GSK-HSD License Agreement").”
FILING10-K0000879407-25-000029cik 0000879407
“On October 7, 2020, Takeda and the Company entered into an Exclusive License and Co-Funding Agreement (the "Takeda License Agreement").”
FILING10-K0000879407-25-000029cik 0000879407
Watchlist prices, news filtered to it, and its next report on your desk.
Arrowhead Pharmaceuticals, Inc. has 0 disclosed suppliers and 5 disclosed customers. Each one is named in an SEC filing, either Arrowhead Pharmaceuticals, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a supplier of Arrowhead Pharmaceuticals, Inc.. Suppliers appear here when Arrowhead Pharmaceuticals, Inc. names them in its own annual report, or when a company names Arrowhead Pharmaceuticals, Inc. as a customer in theirs.
ARWR (Arrowhead Pharmaceuticals, Inc.) has 0 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: AMGN −1.33%, in healthcare.